Medigus: ScoutCam Announces Success of HD Micro Video Camera in NASA’s Robotic Refueling Mission 3
October 23 2020 - 7:35AM
Medigus Ltd. (Nasdaq:MDGS) (TASE:MDGS), a technology company
engaged in advanced medical solutions and innovative internet
technologies, today announced it was informed by ScoutCam Inc.
(OTCQB: SCTC) Medigus’ subsidiary (50.1%) and a leading developer
and manufacturer of customized visual solutions and supplementary
technologies, about the success of its micro ScoutCam 8.0 HD in
NASA’s third Robotic Refueling Mission (RRM3), which was officially
used in-orbit on October 19th-22st, 2020.
The micro camera serves as the borescope camera on NASA’s Visual
Inspection Poseable Invertebrate Robot 2 (VIPIR2), a robotic,
multi-capability inspection tool, which was launched to the
International Space Station on December 5, 2018. Custom-developed
for NASA between 2015 and 2016, micro ScoutCam 8.0 HD features one
module consisting of HD camera and illumination.
NASA’s RRM3 builds on the first two phases of International
Space Station technology demonstrations that tested tools,
technologies, and techniques to refuel and repair satellites in
orbit. The second phase of the Robotic Refueling Mission utilized
micro ScoutCam 1.2, the first generation of the company’s minuscule
video camera.
“We are thrilled that micro ScoutCam 8.0 HD was a success in
NASA’s RRM3 mission," said Yaron Silberman, Chief Executive Officer
of ScoutCam. “We strive to provide our customers with cutting-edge,
custom technologies, and are pleased with our second success with
NASA, as tools like micro ScoutCam 8.0 could be used to aid in the
replenishment of vital supplies in space. We are especially proud
that the continued collaboration is the result of an official
global tender bid with the United States Government, where
ScoutCam’s technology was selected over that of other
companies."
“During the test phase, micro ScoutCam 8.0 HD outperformed its
already successful first-generation predecessor,” said Professor
Benad Goldwasser, ScoutCam’s Chairman of the Board. “The
improvement showcased ScoutCam’s ability to evolve with our
changing technologies and provide our customers with the solution
they need to further their goals. We are extremely pleased with the
outcome and the partnership overall.”
In addition to its miniature size, the versatile micro ScoutCam
8.0 HD camera features state of the art customizable optics and
noteworthy image quality. The waterproof device is also able to
adapt in a variety of extreme temperatures, and withstand various
vibrations, radiation and vacuums.
About Medigus
Medigus is traded on the Nasdaq Capital Market
and the TASE (Tel Aviv Stock Exchange). To learn more about the
company’s advanced technology, please
visit www.medigus.com.
Cautionary Note Regarding Forward Looking
Statements
This press release may contain statements that
are “Forward-Looking Statements,” which are based upon the current
estimates, assumptions and expectations of the company’s management
and its knowledge of the relevant market. The company has tried,
where possible, to identify such information and statements by
using words such as “anticipate,” “believe,” “envision,”
“estimate,” “expect,” “intend,” “may,” “plan,” “predict,”
“project,” “target,” “potential,” “will,” “would,” “could,”
“should,” “continue,” “contemplate” and other similar expressions
and derivations thereof in connection with any discussion of future
events, trends or prospects or future operating or financial
performance, although not all forward-looking statements contain
these identifying words. For example, the company is using
forward-looking statements when it discusses the use of tools like
micro ScoutCam 8.0 to aid in replenishing vital supplies in space,
and ScoutCam’s ability to evolve with its changing technologies and
provide its customers with the solution they need to further their
goals. These forward-looking statements represent company’s
expectations or beliefs concerning future events, and it is
possible that the results described in this press release will not
be achieved, due to inter alia the spread of COVID-19 as well as
the restriction deriving therefrom. By their nature,
Forward-Looking Statements involve known and unknown risks,
uncertainties and other factors which may cause future results of
the company’s activity to differ significantly from the content and
implications of such statements. Other risk factors affecting the
company are discussed in detail in the company’s filings with the
Securities and Exchange Commission. Forward-Looking Statements are
pertinent only as of the date on which they are made, and the
company undertakes no obligation to update or revise any
Forward-Looking Statements, whether as a result of new information,
future developments or otherwise. Neither the company nor its
shareholders, officers and employees, shall be liable for any
action and the results of any action taken by any person based on
the information contained herein, including without limitation the
purchase or sale of company securities. Nothing in this press
release should be deemed to be medical or other advice of any
kind.
Contact (for media only)
Tatiana Yosef
Chief Financial Officer
+972-8-6466-880
ir@medigus.com
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Sep 2023 to Sep 2024